A

Applied Therapeutics
D

APLT

9.62000
USD
0.36
(3.89%)
مغلق
حجم التداول
75,757
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
1,119,349,280
أصول ذات صلة
الأخبار

العنوان: Applied Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.